Literature DB >> 5660210

Vinblastine vs. nitrogen mustard therapy of Hodgkin's disease.

E Z Ezdinli, L Stutzman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5660210     DOI： 10.1002/1097-0142(196808)22:2<473::aid-cncr2820220227>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

Review 1.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Chemotherapy of the lymphomas.

Authors:  I D Todd
Journal:  Proc R Soc Med       Date:  1970-01

3.  A comparison of nitrogen mustard and vinblastine sulfate in the treatment of patients with Hodgkin's disease.

Authors:  R E Alison; D M Whitelaw
Journal:  Can Med Assoc J       Date:  1970-02-14       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.